Zatorowość płucna wysokiego ryzyka w przebiegu infekcji COVID-19  — bezpieczeństwo i skuteczność systemowej trombolizy

Kaziród-Wolski, Karol; Zając, Patrycja; Wałek, Paweł; Sielski, Janusz Krzysztof

doi:10.5603/fc.a2022.0036

Folia Cardiologica

2022

DOI: 10.5603/fc.a2022.0036

|View full text |Cite

Zatorowość płucna wysokiego ryzyka w przebiegu infekcji COVID-19 — bezpieczeństwo i skuteczność systemowej trombolizy

Karol Kaziród-Wolski

Patrycja Zając²,

Paweł Wałek

et al.

Abstract: Coronavirus disease 2019 (COVID-19) is an established risk factor for venous thrombosis. Treatment of pulmonary embolism (PE) of this etiology is standard, but the course of systemic thrombolysis is relatively poorly studied. The authors present the case of an 86-year-old woman with highrisk PE related to COVID-19 infection, who was treated with thrombolytic therapy with a very good clinical effect confirmed in additional studies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 6 publications

(7 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Risk assessment of cardiovascular complications in patients treated for SARS-CoV-2 in the observation in infectious disease department

Zalewski,

Dudziński,

Czyżewski

2023

Emerg Med Serv

View full text Add to dashboard Cite

Aim: Assessment of the risk of pulmonary embolism and myocardial dysfunction based on the measured levels of d-dimer and troponin-T in patients treated in the hospital for COVID-19. Material and methods: The study included a 3-year retrospective analysis of medical records of patients treated at the Independent Public Healthcare Institution. The authors compared the 12 months preceding the epidemic treating this group of patients (without COVID-19) as a control (comparative), and the 24 months of the epidemic in Poland (patients with COVID-19 infection). Results: Statistically significant differences in d-dimer concentrations before and during the pandemic were found (2.150 ± 3.892 vs. 4.990 ± 15.244 vs. 5.032 ± 13.426 μg/ml; P = 0.046). However, there were no statistically significant differences before and during the pandemic in troponin T concentrations (0.027 ± 0.049 vs. 0.032 ± 0.082 vs. 0.034 ± 0.121 ng/mL; P = 0.718). Comparing the periods of the pandemic and the time before the pandemic, the length of the hospitalization period was statistically significantly extended (8 ± 4 vs. 10 ± 7 vs. 12 ± 7 days; P<0.001). Conclusions: Diagnostics consisting in monitoring the level of d-dimer in patients with COVID-19 allows to reduce the risk of complications, including hospital death. Determining the level of d-dimer and troponin-T allows for the implementation of appropriate treatment in patients with COVID-19. Testing the level of d-dimer is important in making clinical decisions against the risk of flordembolism in adult COVID-19 patients.

show abstract

Risk assessment of cardiovascular complications in patients treated for SARS-CoV-2 in the observation in infectious disease department

Zalewski,

Dudziński,

Czyżewski

2023

Emerg Med Serv

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Zatorowość płucna wysokiego ryzyka w przebiegu infekcji COVID-19 — bezpieczeństwo i skuteczność systemowej trombolizy

Cited by 1 publication

References 6 publications

Risk assessment of cardiovascular complications in patients treated for SARS-CoV-2 in the observation in infectious disease department

Risk assessment of cardiovascular complications in patients treated for SARS-CoV-2 in the observation in infectious disease department

Contact Info

Product

Resources

About